CHGCY vs MRK: Which Stock is Better?

Side-by-side comparison of Chugai Pharmaceutical Co Ltd ADR and Merck & Co Inc in 2026

Comparison Updated:

CHGCY

Chugai Pharmaceutical Co Ltd ADR

$32.11

MRK

Merck & Co Inc

$115.46

Key Metrics Comparison

MetricCHGCYMRKWinner
Market Cap$101.69B$291.50BMRK
P/E Ratio35.7316.22MRK
EPS (TTM)$0.86$7.27MRK
Revenue Growth0.1%0.1%CHGCY
Gross Margin71.1%77.2%MRK

Analyze CHGCY

Full quant analysis

Analyze MRK

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CHGCY or MRK a better investment?

Comparing CHGCY and MRK: Chugai Pharmaceutical Co Ltd ADR has a market cap of $101.69B while Merck & Co Inc has $291.50B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CHGCY and MRK?

CHGCY (Chugai Pharmaceutical Co Ltd ADR) and MRK (Merck & Co Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CHGCY or MRK?

Based on P/E ratios, MRK trades at a lower multiple (16.2x vs 35.7x).

Which is growing faster: CHGCY or MRK?

CHGCY has higher revenue growth at 0.1% vs 0.1% for MRK.

Which company is more profitable: CHGCY or MRK?

Merck & Co Inc (MRK) has higher gross margins at 77.2% compared to 71.1% for CHGCY.

Which is the larger company: CHGCY or MRK?

Merck & Co Inc (MRK) is larger with a market cap of $291.50B compared to $101.69B for CHGCY.

Should I buy CHGCY or MRK in 2026?

Both CHGCY and MRK have investment merit. CHGCY trades at $32.11 while MRK trades at $115.46. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CHGCY and MRK stock?

Key differences: Market Cap ($101.69B vs $291.50B), P/E Ratio (35.7x vs 16.2x), Revenue Growth (0.1% vs 0.1%), Gross Margin (71.1% vs 77.2%).

Popular Stock Comparisons